Cleared Traditional

Chondral Quant (K231351) - FDA 510(k) Clearance

Class II Radiology device cleared through predicate-based substantial equivalence - typically does not require clinical trials.

Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Jul 2023
Decision
65d
Days
Class 2
Risk

K231351 is an FDA 510(k) clearance for the Chondral Quant. Classified as System, Image Processing, Radiological within the LLZ classification (a category encompassing advanced image processing and PACS-adjacent software), Class II - Special Controls.

Submitted by Siemens Medical Soultions USA, Inc. (Malvern, US). The FDA issued a Cleared decision on July 13, 2023 after a review of 65 days - a notably fast clearance cycle.

This device falls under the Radiology FDA review panel, regulated under 21 CFR 892.2050 - the FDA radiology and imaging software oversight framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Incremental AI imaging tool. Moderate equivalence dependency. Overall, this clearance reflects a predicate-aligned approval typical of modern AI radiology extensions - not a novel clinical breakthrough, but a validated iteration within an established regulatory category.

View all Siemens Medical Soultions USA, Inc. devices

Submission Details

510(k) Number K231351 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received May 09, 2023
Decision Date July 13, 2023
Days to Decision 65 days
Submission Type Traditional
Review Panel Radiology (RA)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
42d faster than avg
Panel avg: 107d · This submission: 65d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

Device Classification

Product Code LLZ System, Image Processing, Radiological
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 892.2050
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Radiology devices follow this clearance model.

Regulatory Peers - LLZ System, Image Processing, Radiological

All 799
Devices cleared under the same product code (LLZ) and FDA review panel - the closest regulatory comparables to K231351.
Cercare Medical Neurosuite
K230016 · Cercare Medical A/S · Jul 2023
JiveX (Model Number / Release: 5.4)
K231041 · Visus Health IT GmbH · Jul 2023
XR90 (XR90-SYS)
K223125 · Mediview Xr, Inc. · Jul 2023
Pixyl.Neuro
K213253 · Pixyl SA · Jun 2023
Medisystem Pacs
K223048 · Medilab Manutencao E Sitemas Ltda · Jun 2023
CT Perfusion V1.0
K223091 · Olea Medical · Jun 2023